In Europe

• Directive 2007/47/CEE to be fully effective on March 21, 2010
• New Revision MEDDEV 2.1/3 Rev.3: Borderline products, drug-delivery products and medical devices incorporating,as integral part, an ancillary medicinal substance or an ancillary human blood derivative - December 2009
• New Revision MEDDEV 2.7/1 Rev.3: Clinical evaluation: Guide for manufacturers and notified bodies
• New Revision MEDDEV 2.12/1 Rev.6: Medical devices vigilance system
• Interpretation of the relation between the revised Directives 90/385/EEC and 93/42/EEC concerning (active implantable) medical devices and Directive 2006/42/EC on machinery
• Interpretation of the relation between the revised Directive 93/42/EEC concerning medical devices and Directive 89/686/EEC on personal protective equipment
• Interpretative document of the Commission's services implementation of directive 2007/47/EC amending directives 90/385/EEC, 93/42/EEC and 98/8/EC